Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Comment by jayjay2020on Jul 16, 2019 12:06pm
132 Views
Post# 29925263

RE:Aphria Inc (NYSE:APHA) Expected to Announce Quarterly Sales

RE:Aphria Inc (NYSE:APHA) Expected to Announce Quarterly Sales
quietobserver wrote:

Wall Street analysts expect that Aphria Inc (NYSE:APHA) will report sales of $73.60 million for the current quarter, according to Zacks Investment Research. Two analysts have provided estimates for Aphria’s earnings, with the lowest sales estimate coming in at $57.80 million and the highest estimate coming in at $89.40 million. Aphria posted sales of $9.36 million in the same quarter last year, which would indicate a positive year over year growth rate of 686.3%. The company is expected to announce its next quarterly earnings report on Wednesday, August 7th.

On average, analysts expect that Aphria will report full year sales of $160.04 million for the current fiscal year, with estimates ranging from $138.92 million to $170.37 million. For the next year, analysts anticipate that the company will post sales of $536.47 million, with estimates ranging from $391.54 million to $676.13 million. Zacks’ sales averages are an average based on a survey of research firms that cover Aphria.

Aphria (NYSE:APHA) last announced its quarterly earnings results on Monday, April 15th. The company reported ($0.15) earnings per share for the quarter, missing the consensus estimate of ($0.04) by ($0.11). The company had revenue of $55.24 million for the quarter, compared to the consensus estimate of $41.11 million.

 

APHA has been the topic of a number of analyst reports. Jefferies Financial Group reiterated a “buy” rating and set a C$15.00 price objective on shares of Aphria in a research report on Friday, May 24th. Zacks Investment Research upgraded shares of Garrett Motion from a “sell” rating to a “hold” rating in a research report on Friday, May 10th. Clarus Securities initiated coverage on shares of Aphria in a research report on Tuesday, April 16th. They set a “buy” rating and a $22.75 price objective on the stock. Finally, ValuEngine upgraded shares of ZTE CORP/ADR from a “hold” rating to a “buy” rating in a research report on Monday, April 15th. Four research analysts have rated the stock with a hold rating and five have issued a buy rating to the company. The company presently has an average rating of “Buy” and a consensus target price of $14.75.

Shares of APHA opened at $6.29 on Tuesday. The stock has a fifty day simple moving average of $6.84. Aphria has a fifty-two week low of $3.75 and a fifty-two week high of $16.86.

A number of hedge funds have recently bought and sold shares of APHA. Advisory Services Network LLC grew its holdings in shares of Aphria by 45.3% in the first quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock worth $52,000 after purchasing an additional 1,755 shares during the last quarter. Shell Asset Management Co. grew its holdings in shares of Aphria by 17.9% in the first quarter. Shell Asset Management Co. now owns 17,723 shares of the company’s stock worth $165,000 after purchasing an additional 2,687 shares during the last quarter. Financial Advocates Investment Management bought a new position in shares of Aphria in the fourth quarter worth about $89,000. Creative Planning grew its holdings in shares of Aphria by 6.4% in the first quarter. Creative Planning now owns 72,342 shares of the company’s stock worth $674,000 after purchasing an additional 4,351 shares during the last quarter. Finally, Cetera Advisor Networks LLC grew its holdings in shares of Aphria by 15.1% in the first quarter. Cetera Advisor Networks LLC now owns 35,717 shares of the company’s stock worth $340,000 after purchasing an additional 4,684 shares during the last quarter. Institutional investors and hedge funds own 8.55% of the company’s stock.

I think it breaks $90M

Bullboard Posts